GL1X · GenesisL1 explorer

Research workbench

Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor (S)-2-(((1R,4S)-4-(4-amino-5-(4-phenoxyphenyl)-7H-PYRROLO[2,3- D]PYRIMIDIN-7-YL)CYCLOHEXYL)AMINO)-N,4-dimethylpentanamide

Analyse Crystal structure of hck complexed with a pyrrolo-pyrimidine inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5H0G
Type
protein
Length
447 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase hck
EC
2.7.10.2
UniProt
P08631
Ligands
OOU
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase hck (EC 2.7.10.2)protein44730% helix, 22% strandP08631

Ligands and binding sites

  • OOU · (2~{S})-2-[[4-[4-azanyl-5-(4-phenoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]amino]-~{N},4-dimethyl-pentanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111910.730.76103empty
24620.720.8148OOU

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5H0G · Crystal structure of HCK complexed with a pyrrolo-pyrimidine inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.